Hannah Valantine

Hannah Valantine

Director/Board Member at CAREDX, INC.

Net worth: 3 M $ as of 29/09/2026

74 year
Health Technology
Consumer Services
Commercial Services

Profile

Dr. Hannah A. Valantine, MD, is an Independent Director at BridgeBio Pharma, Inc., an Independent Director at CareDx, Inc., an Independent Director at Pacific Biosciences of California, Inc., a Principal at Hav LLC, a Professor at Stanford University School of Medicine and a Member at National Academy of Medicine (United States).
She is on the Board of Directors at BridgeBio Pharma, Inc., CareDx, Inc. and Pacific Biosciences of California, Inc. She received her undergraduate degree from the University of London and a doctorate degree from the University of London.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
15/07/2026 36,686 ( 0.07% ) 2 M $ 29/09/2026
22/06/2026 9,657 ( 0% ) 635 431 $ 29/09/2026
02/06/2026 22,821 ( 0.01% ) 54 086 $ 29/09/2026

Hannah Valantine active positions

CompaniesPositionStart
CAREDX, INC. Director/Board Member 30/06/2021
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Director/Board Member 15/06/2021
BRIDGEBIO PHARMA, INC. Director/Board Member 22/10/2021
Corporate Officer/Principal 31/12/1986
Hav LLC
Founder 31/12/2020
Corporate Officer/Principal -

Education of Hannah Valantine

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

84

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Health Technology

Consumer Services

Commercial Services

Consumer Services

Health Technology

Hav LLC

  1. Stock Market
  2. Insiders
  3. Hannah Valantine